Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
Inv. presentation
Director departure
DERMA SCIENCES, INC. (DSCI) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/24/2017 8-K Form 8-K - Current report
01/25/2017 8-K Form 8-K - Current report
01/17/2017 8-K Form 8-K - Current report
01/17/2017 8-K Form 8-K - Current report
09/08/2016 8-K Form 8-K - Current report
08/26/2016 8-K Form 8-K - Current report
08/11/2016 8-K Form 8-K - Current report
07/29/2016 8-K Investor presentation
Docs: "Separation Agreement",
"# # #",
"Slide Presentation"
06/03/2016 8-K Form 8-K - Current report
03/01/2016 8-K Resignation/termination of a director
12/21/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, between Derma Sciences, Inc. and Edward J. Quilty",
"DERMA SCIENCES ANNOUNCES LEADERSHIP AND CEO TRANSITION"
08/07/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/29/2015 8-K Submission of Matters to a Vote of Security Holders
05/23/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2014 Director Compensation Program",
"Amended and Restated Derma Sciences, Inc. 2012 Equity Incentive Plan"
03/27/2014 8-K Resignation/termination of a director
01/27/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Purchase Agreement, by and between the Company and Piper Jaffray & Co. and Canaccord Genuity Inc., as Representatives of the several Underwriters",
"Purchase Agreement, by and between the Company and Piper Jaffray & Co. and Canaccord Genuity Inc., as Representatives of the several Underwriters",
"Opinion of Thompson Hine LLP",
"Opinion of Thompson Hine LLP",
"DERMA SCIENCES ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF COMMON STOCK",
"DERMA SCIENCES ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF COMMON STOCK",
"Derma Sciences Announces Pricing of UNDERWRITTEN PUBLIC Offering of Common Stock",
"Derma Sciences Announces Pricing of UNDERWRITTEN PUBLIC Offering of Common Stock"
01/21/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Derma Sciences Announces Record Revenues for the 2013 Fourth Quarter and Full Year, Introduces 2014 Revenue Guidance, Provides Update on DSC127 Phase 3 Clinical Trials Expects 2014 total revenue of $92 million, up 15.5% over 2013, organic advanced wound care revenue growth of 30% to 40%"
01/17/2014 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Derma Sciences Enters the Skin Substitute Market with Licensing Agreement for Innovative Amniotic Membrane Wound Care Products Commercial launch into this $500 million market, along with its drug candidate for the treatment of diabetic foot ulcers, underscores company’ s commitment to regenerative medicine"
09/05/2013 8-K Form 8-K - Current report
08/12/2013 8-K Form 8-K - Current report
05/24/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2013 Director Compensation Program",
"Amended and Restated Derma Sciences, Inc. 2012 Equity Incentive Plan"
04/01/2013 8-K Resignation/termination of a director
12/21/2012 8-K Form 8-K - Current report
12/07/2012 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Opinion of Thompson Hine LLP",
"DERMA SCIENCES ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING OF COMMON STOCK",
"Derma Sciences Announces Pricing of UNDERWRITTEN PUBLIC Offering of Common Stock"
09/20/2012 8-K Form 8-K - Current report
07/18/2012 8-K Form 8-K - Current report
07/03/2012 8-K Form 8-K - Current report
06/05/2012 8-K Form 8-K - Current report
05/18/2012 8-K Form 8-K - Current report
05/04/2012 8-K Form 8-K - Current report
04/20/2012 8-K Form 8-K - Current report
04/04/2012 8-K Form 8-K - Current report
03/30/2012 8-K Form 8-K - Current report
03/16/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy